Company / Shareholders' Equity
Citius Pharmaceuticals, Inc. Shareholders' Equity History
FY2011-FY2013 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Shareholders' Equity
-$2.9M
FY2013
5-year range
-$2.9M / -$23.8K
FY2011-FY2013
Trend
-79.8%
vs FY2012
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Citius Pharmaceuticals, Inc. reports negative total equity of -$3M in FY2013. Negative equity can occur when accumulated losses exceed contributed capital, as reported in the balance sheet from the SEC filing.
Based on SEC 10-K filings.
-$3M in FY2013.
Declined from -$23,841 to -$3M over the past 2 years.
Shareholders' Equity over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2013, shareholders' equity decreased 79.8% year-over-year.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Shareholders' EquityValue | YoY GrowthYoY |
|---|---|---|
| FY2013 | -$2.9M | -79.8% |
| FY2012 | -$1.6M | -6668.8% |
| FY2011 | -$23.8K | - |
As of FY2013 · SEC 10-K · Updated Jun 22, 2026